US2013123212A1PendingUtilityA1
Anti-fatigue composition, formulation and use thereof
Est. expiryJul 27, 2030(~4 yrs left)· nominal 20-yr term from priority
A61P 43/00A61P 35/00A61P 39/00A61P 39/06A61P 25/24A61K 9/2018A61K 47/10A61K 36/815A61K 9/4858A61K 31/715A61K 9/1623A61K 9/08A23V 2200/31A61P 25/00A61K 31/575A23L 33/10A23V 2002/00
29
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
An anti-fatigue composition consisting of 20(S)-protopanoxadiol and lycium barbarum polysaccharide. Experiments prove that the composition exhibits a significant anti-fatigue effect. In comparison with the effect attained by the single use of lycium barbarum polysaccharide or 20(S)-protopanoxadiol, the combined use of 20(S)-protopanoxadiol and lycium barbarum polysaccharide exerts an obvious a clear synergistic effect.
Claims
exact text as granted — not AI-modified1 . An anti-fatigue composition consisting of 20(S)-protopanoxadiol and lycium barbarum polysaccharide.
2 . The composition according to claim 1 , wherein the weight ratio of the 20(S)-protopanoxadiol and lycium barbarum polysaccharide is 1:50 to 1:1000.
3 . A formulation comprising the composition according to claim 1 , wherein the formulation consists of 20(S)-protopanoxadiol, lycium barbarum polysaccharide and pharmaceutically acceptable excipients.
4 . The formulation according to claim 3 , wherein the formulation is in form of tablets, pills, capsules, granules or oral solution.
5 . A method for relieving fatigue, comprising administering the composition of claim 1 to a subject.
6 . A method for relieving fatigue, comprising administering the formulation of claim 3 to a subject.
7 . The method of claim 5 , wherein the fatigue results from various causes.
8 . The method of claim 7 , wherein the fatigue results from diseases.
9 . The method of claim 8 , wherein the fatigue results from cancer or depression.
10 . (canceled)
11 . The composition according to claim 1 , wherein the weight ratio of the 20(S)-protopanoxadiol and lycium barbarum polysaccharide is 0.01-50 to 60-480.
12 . The composition according to claim 11 , wherein the weight ratio of the 20(S)-protopanoxadiol and lycium barbarum polysaccharide is 0.01-5 to 120-480.
13 . The formulation according to claim 3 , wherein the weight ratio of the 20(S)-protopanoxadiol and lycium barbarum polysaccharide is 0.01-50 to 60-480.
14 . The formulation according to claim 13 , wherein the weight ratio of the 20(S)-protopanoxadiol and lycium barbarum polysaccharide is 0.01-5 to 120-480.Join the waitlist — get patent alerts
Track US2013123212A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.